Efficacy and Safety of Low-Dose Peginterferon Alpha-2a Plus Ribavirin on Chronic Hepatitis C

Background. The purpose of this study was to assess the efficacy and safety of low-dose peg-IFN α-2a plus ribavirin on the treatment of patients with chronic hepatitis C virus (HCV) infection. Patients and Methods. A total of 243 HCV patients treated with different doses of peg-IFN α-2a plus ribavir...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Zehui, Fan, Ke, Wang, Xiaohong, Mao, Qing, Deng, Guohong, Wang, Yuming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3519007/
https://www.ncbi.nlm.nih.gov/pubmed/23258976
http://dx.doi.org/10.1155/2012/302093

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3519007/
https://www.ncbi.nlm.nih.gov/pubmed/23258976
http://dx.doi.org/10.1155/2012/302093

Ejemplares similares